Science & Enterprise subscription

Follow us on Twitter

  • New contributed post on Science and Enterprise: Ships Are Becoming Safer With Technology
    about 51 mins ago
  • A panel of data and behavioral scientists envision great potential for blockchain in science, but show few cases o…
    about 21 hours ago
  • New post on Science and Enterprise: Blockchain and Science, Not Ready for Prime Time #Science #Business #AAASmtg
    about 21 hours ago
  • New contributed post on Science and Enterprise: Slips And Falls, Underestimated Workplace Hazards
    about 22 hours ago
  • An experimental drug is shown in a clinical trial and computer modeling to reduce the mass of smooth muscle tissue…
    about 2 days ago

Please share Science & Enterprise

Follow by Email
Visit Us

Analytics Company, Johns Hopkins to Study Asthma Genomes

DNA strand (


Knome Inc., a genomics analysis company in Cambridge, Massachusetts, says it received a contract from Johns Hopkins University School of Medicine in Baltimore to provide its software and services for a study of genetic variants that contribute to asthma in African American and African Caribbean populations. Financial terms of the contract were not disclosed.

The study, says the company, involves analysis of 1,000 genomes from participants of African descent from 15 academic research centers across the United States, the Caribbean, South America, and research sites in west Africa. Knome expects its technology will be used to annotate the collected genomes, and transform each genome’s raw sequence information into a data set suitable for comparative interpretation.

Knome’s services include knomeBase, that the company says transforms human genome sequence data into a format optimized for fast interpretation. The company’s literature says the knomeBase service standardizes, annotates, compares, and distills raw sequence data. Knome also provides software applications, libraries, and scripts for further interpretation or testing of the data.

The company also announced the appointment of Martin Tolar as its Chief Executive Officer. Tolar is a former biotechnology executive and professor of neurology at Yale University medical center.

Read more: Dana-Farber, Brigham and Women’s Establish Genomic Database

*     *     *

Please share Science & Enterprise ...

Comments are closed.